Technology Transfer Refer a Patient Clinical Trials Find a Researcher Transforming Our Discoveries Into Therapeutics The Technology Transfer Office embodies the spirit of the National Jewish Health brand promise, Breathing Science is Life®. We accelerate the development of basic scientific research toward clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization. National Jewish Health currently has in its portfolio: 114 active technologies developed from our research 89 active U.S. patents protecting these technologies 50 percent of those active US patents are licensed to biotechnology companies for the development of therapeutics Additionally, in the 25 years since the Technology Transfer Office was created, National Jewish Health has: executed 319 license agreements, of which 164 are still active; executed a total of 2,563 material transfer agreements; and helped create 11 start-up companies. Technologies from National Jewish Health To browse a list of the technologies ready for licensing or further development, select one of the following: Therapeutics Diagnostics Digital Health Research Tools: Antibodies, Cell Lines, Animal Models & Transgenic Mice Biomedical Devices Start-Up Companies created with National Jewish Health technologies Featured Technology: Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo Staff Contact Information Emmanuel Hilaire, PhD Director Phone: 303.398.1262 HilaireE@njhealth.org Stephanie Piersma, MLIS Sr. Program Administrator Phone: 303.398.1045 PiersmaS@njhealth.org National Jewish Health Technology Transfer Office 1400 Jackson St., M206 Denver, CO 80206 Fax: 303.270.2352